Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (Luteinizing hormone-releasing hormone)
- 31 October 1992
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 164 (4) , 348-353
- https://doi.org/10.1016/s0002-9610(05)80903-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Whatʼs New In General SurgeryAnnals of Surgery, 1988
- PROTECTIVE EFFECT OF OESTROGEN IN PANCREATIC CANCERThe Lancet, 1987
- Carcinoma of the exocrine pancreas: A sex hormone responsive tumour?British Journal of Surgery, 1987
- Androgen receptor in human normal and malignant pancreatic tissue and cell linesCancer, 1986
- Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.Proceedings of the National Academy of Sciences, 1984
- The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapyBritish Journal of Surgery, 1982
- Demographic characteristics of cancer of the pancreas: Mortality, incidence, and survivalCancer, 1981
- Effects of gastrointestinal hormones on pancreatic growthCancer, 1981
- Reporting results of cancer treatmentCancer, 1981
- Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreasThe American Journal of Surgery, 1974